𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Double-blind placebo-controlled trial of corticosteroids in children with postpericardiotomy syndrome

✍ Scribed by N. J. Wilson; S. A. Webber; M. W. H. Patterson; G. G. S. Sandor; M. Tipple; J. LeBlanc

Publisher
Springer
Year
1994
Tongue
English
Weight
432 KB
Volume
15
Category
Article
ISSN
0172-0643

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, double-blind, placebo-contro
Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia
✍ Mark Davenport; Mark D. Stringer; Sarah A. Tizzard; Patricia McClean; Giorgina M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

The objective of this study was to evaluate adjuvant corticosteroids after Kasai portoenterostomy for biliary atresia. The study consisted of a prospective, 2-center, double-blind, randomized, placebo-controlled trial of post-Kasai portoenterostomy corticosteroids (oral prednisolone: 2 mg/kg/day fro

A double blind randomized placebo contro
A double blind randomized placebo control trial of levetiracetam in tourette syndrome
✍ Constance L. Smith-Hicks; Dana D. Bridges; Nina P. Paynter; Harvey S. Singer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract The objective of this study was to investigate the effectiveness of levetiracetam for the treatment of tics in children with Tourette syndrome (TS). Levetiracetam, an atypical anticonvulsant, has been suggested in open‐label protocols to be an effective tic‐suppressing agent in individu

Etanercept in Sjögren's syndrome: A twel
Etanercept in Sjögren's syndrome: A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial
✍ Vidya Sankar; Michael T. Brennan; Marc R. Kok; Rose Anne Leakan; Janine A. Smith 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

## Abstract ## Objective To assess the safety and potential efficacy of etanercept in the treatment of Sjögren's syndrome (SS). ## Methods This pilot study was a 12‐week randomized, double‐blind, placebo‐controlled trial of etanercept, with 14 subjects in each group. Patients received 25 mg of e